Cybrdi Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Sales/Revenue
1,473.60
819.70
546.30
783.20
574.30
Cost of Goods Sold (COGS) incl. D&A
1,172.30
631.00
875.30
999.00
740.90
Gross Income
301.40
188.70
329.00
215.80
166.60
SG&A Expense
863.70
1,062.00
363.90
254.00
375.70
EBIT
562.40
873.30
692.90
469.80
542.30
Unusual Expense
-
-
37.10
38.00
-
Non Operating Income/Expense
99.40
33.10
14.60
28.40
148.80
Interest Expense
-
1.40
-
194.60
221.00
Pretax Income
659.50
841.50
739.20
654.80
614.50
Income Tax
35.10
-
-
0.90
2.20
Consolidated Net Income
694.70
841.50
739.20
655.60
616.70
Net Income
596.90
750.70
599.80
529.80
548.40
Net Income After Extraordinaries
596.90
750.70
599.80
529.80
548.40
Net Income Available to Common
596.90
750.70
599.80
529.80
548.40
EPS (Basic)
0.01
0.01
0.01
0.00
0.00
Basic Shares Outstanding
50,456.60
64,963.20
85,879.70
120,225.30
120,225.30
EPS (Diluted)
0.01
0.01
0.01
0.00
0.00
Diluted Shares Outstanding
50,456.60
64,963.20
85,879.70
120,225.30
120,225.30
EBITDA
391.90
700.70
424.70
221.10
330.00
Non-Operating Interest Income
2.20
-
5.50
-
-
Minority Interest Expense
97.70
90.80
139.40
125.80
68.40

About Cybrdi

View Profile
Address
No. 29, Chang'an South Road
Xi'an Shaanxi 710061
China
Employees -
Website http://www.cybrdi.com
Updated 07/08/2019
Cybrdi, Inc. is a holding company, which engages in the business of the distribution of magnetic media products, primarily blank audio and video cassettes. It manufactures both human and animal tissue micro-array for a wide variety of scientific uses, including drug discovery and development. The company is operating through three operating segments and two reportable segments, including Chaoying Biotech and SD Chaoying.